Michigan Biosciences Industry Association Logo

Advocacy

Stay informed on advocacy efforts driving growth and innovation in the bio-industry. This category features updates, initiatives, and insights focused on promoting policies and actions that support our thriving community.

Advocacy Advocacy : Federal Advocacy Advocacy : State Advocacy Association Updates BioConnections® Jobs Event Event : Industry Event Event : MichBio Advocacy Events Event : MichBio Networking Event Event : MichBio Signature Event Event : MichBio Webinar Event : Partner Event Member Feature News News : Industry News News : Member News News : MichBio News/Statement News : Michigan News
New NAM Center Could Help Companies Strengthen Drug Development Decisions
Posted In: Federal Advocacy,
Date posted Oct 7

For biotechnology companies, adopting a new testing method requires confidence that its results will support both scientific decisions and...

Read Post
CMS Finalizes Narrower GLOBE Drug Pricing Model; Concerns for Innovation
Posted In: Federal Advocacy,
Date posted Oct 7

CMS has finalized its Global Benchmark for Efficient Drug Pricing (GLOBE) Model, establishing a mandatory Medicare demonstration that uses...

Read Post
Competing For Michigan's Life Sciences Future: The Gubernatorial Candidates Weigh In
Posted In: State Advocacy,
Date posted Sep 29

The policies and priorities of Michigan's next Governor will help shape the future of one of the state's most innovative and economically...

Read Post
MichBio Urges Congressional Review of Proposed NIAID Funding Transfers
Posted In: Federal Advocacy,
Date posted Sep 20

MichBio is calling on Michigan’s congressional delegation to intervene before research funding from the National Institutes of Health (NIH)...

Read Post
Bipartisan Bill Would Make Rare Pediatric Drug Incentive Permanent
Posted In: Federal Advocacy,
Date posted Sep 20

A bipartisan group of House lawmakers has introduced legislation to permanently authorize an important federal incentive for rare pediatric drug...

Read Post
Senate Farm Bill Advances with Significant Opportunities for Michigan's Bioeconomy
Posted In: Federal Advocacy,
Date posted Sep 20

The Senate Committee on Agriculture, Nutrition, and Forestry advanced the Agricultural Act of 2026 on September 16, moving a long-delayed Farm...

Read Post
SB 1166 would Undercut Veterinary Authority and Burden Michigan Research
Posted In: State Advocacy,
Date posted Sep 20

State Sen. Dayna Polehanki has introduced another proposal regulating animals in research. Senate Bill 1166, introduced September 10, would amend...

Read Post
SB 1177 Risks Medical-Product Shortages Despite Industry Concerns
Posted In: State Advocacy,
Date posted Sep 20

State Sen. Sue Shink, joined by Sen. Rosemary Bayer, has introduced legislation that would restrict the manufacture, sale and distribution of...

Read Post
PDUFA VIII: A Blueprint For A More Predictable FDA
Posted In: Federal Advocacy,
Date posted Sep 2

The Prescription Drug User Fee Act, or PDUFA, allows the U.S. Food and Drug Administration (FDA) to collect fees from pharmaceutical and...

Read Post
FDA–SEC Agreement Raises the Stakes For Biotech Investor Disclosures
Posted In: Federal Advocacy,
Date posted Sep 2

The U.S. Food and Drug Administration (FDA) and Securities and Exchange Commission (SEC) have signed a first-of-its-kind memorandum of...

Read Post
MFN Deals Move Beyond Big Pharma - What it Means For Biotech Startups
Posted In: Federal Advocacy,
Date posted Sep 2

The White House’s agreements with nine additional manufacturers signal that pricing pressure is extending deeper into the biopharmaceutical...

Read Post
GLOBE and GUARD Could Reshape Biotech Out-Licensing
Posted In: Federal Advocacy,
Date posted Sep 2

Two proposed Medicare payment models could have consequences well beyond drug pricing. The Global Benchmark for Efficient Drug Pricing, or...

Read Post